⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28187462 | 0.98 | — | — | |
| SCHEMBL13548386 | 0.82 | CYP2C19 (0.44) | — | |
| SCHEMBL2311217 | 0.81 | CYP2C19 (0.46) | — | |
| SCHEMBL1844674 | 0.81 | ADRB2 (0.40) | — | |
| SCHEMBL1843939 | 0.79 | ADRB2 (0.39) | — | |
| SCHEMBL4574553 | 0.79 | — | — | |
| SCHEMBL22593333 | 0.79 | — | — | |
| SCHEMBL1039947 | 0.78 | — | — | |
| SCHEMBL1625539 | 0.78 | — | — | |
| SCHEMBL3787961 | 0.78 | FDPS (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2888252-B1 | BENZOFURAZAN ANTI-AMYLOID COMPOUNDS AND METHODS | TREVENTIS CORP (US) | 2017-06-07 | — | — | EP | claimed |
| US-20160264535-A1 | BENZOFURAZAN ANTI-AMYLOID COMPOUNDS AND METHODS | TREVENTIS CORPORATION (US) | 2016-09-15 | — | — | US | claimed |
| US-9328078-B2 | Benzofurazan anti-amyloid compounds and methods | TREVENTIS CORPORATION (US) | 2016-05-03 | — | — | US | claimed |
| US-20150266838-A1 | BENZOFURAZAN ANTI-AMYLOID COMPOUNDS AND METHODS | TREVENTIS CORPORATION | 2015-09-24 | — | — | US | claimed |
| CN-104768949-A | Benzofurazan anti-amyloid compounds and methods | TREVENTIS CORP | 2015-07-08 | — | — | CN | claimed |
| EP-2888252-A2 | BENZOFURAZAN ANTI-AMYLOID COMPOUNDS AND METHODS | Treventis Corporation (US) | 2015-07-01 | — | — | EP | claimed |
| WO-2014031873-A2 | BENZOFURAZAN ANTI-AMYLOID COMPOUNDS AND METHODS | TREVENTIS CORPORATION (US) | 2014-02-27 | — | — | WO | claimed |
| US-20080200454-A1 | CARBON-LINKED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S | SUNESIS PHARMACEUTICALS, INC. | 2008-08-21 | — | — | US | claimed |
| WO-2008100618-A2 | CARBON-LINKED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S | SUNESIS PHARMACEUTICALS, INC. (US) | 2008-08-21 | — | — | WO | claimed |
| EP-1233786-A2 | PRODUCT COMPRISING AT LEAST A NO SYNTHASE INHIBITING SUBSTANCE ASSOCIATED WITH AT LEAST A PHOSPHOLIPASE A2 INHIBITING SUBSTANCE | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2002-08-28 | — | — | EP | claimed |
| WO-2001032216-A2 | PRODUCT COMPRISING AT LEAST A NO SYNTHASE INHIBITING SUBSTANCE ASSOCIATED WITH AT LEAST A PHOSPHOLIPASE A2 INHIBITING SUBSTANCE | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2001-05-10 | — | — | WO | claimed |
| EP-3351533-B1 | BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME | KAKEN PHARMA CO LTD (JP) | 2025-07-23 | — | — | EP | disclosed |
| US-12221434-B2 | Sulfonamide carboxamide compounds | INFLAZOME LIMITED (IE) | 2025-02-11 | — | — | US | disclosed |
| US-20230338546-A1 | ORAL FORMULATIONS OF KAPPA OPIOID RECEPTOR AGONISTS | CARA THERAPEUTICS INC (US) | 2023-10-26 | — | — | US | disclosed |
| US-20230338546-A1 | ORAL FORMULATIONS OF KAPPA OPIOID RECEPTOR AGONISTS | CARA THERAPEUTICS INC (US) | 2023-10-26 | — | — | US | disclosed |
| US-5597926-A | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1997-01-28 | — | — | US | disclosed |
| US-5554783-A | (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE | ABBOTT LABORATORIES (US) | 1996-09-10 | — | — | US | disclosed |
| US-5541334-A | TREATING HIV | ABBOTT LABORATORIES (US) | 1996-07-30 | — | — | US | disclosed |
| US-5354866-A | Treating HIV infections | ABBOTT LABORATORIES (US) | 1994-10-11 | — | — | US | disclosed |
| EP-0486948-A2 | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1992-05-27 | — | — | EP | disclosed |